0:000:00
<p>Dr. Shaalan Beg and Dr. David Wang discuss key abstracts in GI cancers from the 2025 ASCO Gastrointestinal Cancers Symposium, including major advances in CRC, neoadjuvant approaches in esophageal cancer, and innovative studies on ctDNA.</p> <p><span style= "text-decoration: underline;"><strong>TRANSCRIPT</strong></span></p> <p class="MsoNormal"><strong><span style= "font-size: 12.0pt; line-height: 107%; font-family: 'Calibri',sans-serif;"> Dr. Shaalan Beg:</span></strong> <span style= "font-size: 12.0pt; line-height: 107%; font-family: 'Calibri',sans-serif;"> Hello and welcome to the <em>ASCO Daily News</em> Podcast. I'm Dr. Shaalan Beg. I'm a medical oncologist and an adjunct associate professor at UT Southwestern Medical Center in Dallas. Today, we're bringing you some key highlights from the 2025 ASCO Gastrointestinal Cancers Symposium, and I'm delighted to be joined by the chair of GI25, Dr. David Wang. Dr. Wang is a GI medical oncologist at the University of Michigan.</span></p...